← All stocks

Opus Genetics, Inc.

IRD Net selling
CIK 0001228627 #3431 in the set updated 17 Sep 2026
Bought (120 mo)
$931.22K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$16.77M
$0.00 on a plan · $175.38K straight out of an exercise
Sold at will
$16.59M
17 of 18 sales
Net
−$15.84M
−$15.66M against sales at will

By person

27 insiders · 53 transactions
15.5×

Dr. George Magrath holds 15.5 times base salary in stock. $9.31M of shares against $598.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Dr. George Magrath last reported holding, valued at $4.54, the price Common Stock was last bought or sold at on the open market here, on 3 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Foundation Fighting Blindness Retinal Degeneration Fund entity
Director
$16.00M (2)
−$16.00M
3,792,171
$17.23M
+47.9%
Gallagher Cam
Director
$323.69K (3)
+$323.69K
2,966,111
$13.48M
+3,474%
Gagnon Robert E.
Chief Financial Officer
$190.81K (3)
−$190.81K
556,375
$2.53M
Ahn Chang Ho
Director
$175.38K (1) scheduled
−$175.38K
6,510,000
$29.58M
0.0%
Benton Susan
Director
$91.40K (1)
+$91.40K
243,894
$1.11M
Pepose Jay
Director
$90.11K (2)
+$90.11K
180,458
$819.87K
+8,440%
SCHACHLE JOSEPH K
Chief Operating Officer
$4.10K (1)
$57.70K (3)
−$53.60K
291,440
$1.32M
Jayagopal Ashwath
Chief Scientific & Dev. Ofc.
$6.18K (1)
$58.20K (2)
−$52.02K
509,233
$2.31M
Magrath George
Chief Executive Officer
$256.58K (5)
$204.90K (3)
+$51.68K
2,048,485
$9.31M
YERXA BENJAMIN R
President
$9.83K (1)
$61.19K (2)
−$51.35K
704,106
$3.20M
Sooch Mina
President and CEO
$51.18K (3)
+$51.18K
430,501
$1.96M
Swirsky Douglas J
President and CEO
$31.72K (1)
+$31.72K
50,000
$227.17K
Zaremba Rabourn Amy
Head of Fin. Quality Assurance
$23.31K (2)
−$23.31K
188,671
$857.19K
Jhaveri Nirav S.
Chief Financial Officer
$21.00K (1)
+$21.00K
194,293
$882.73K
MANUSO JAMES S J
Director
$16.95K (3)
+$16.95K
317,318
$1.44M
Nolan Lisa
Chief Business Officer
$12.96K (1)
+$12.96K
23,250
$105.63K
Price Ben Gil
Director
$9.14K (1)
+$9.14K
15,000
$68.15K
Beever Charles
Director
$6.38K (1)
+$6.38K
11,000
$49.98K
+1,000%
Ainsworth Sean
Director
(1)
$0.00
321,692
$1.46M
MEYER ALAN R
Director
(1)
$0.00
487,029
$2.21M
Rodgers Richard J
Director
(1)
$0.00
343,022
$1.56M
Bennett Jean
Director
259,019
$1.18M
Hoffmann Bernhard
SVP of Corp. Dev.
185,446
$842.54K
Graves Adrienne L
Director
127,514
$579.33K
Patel Ronil A.
Chief Business Officer
90,714
$412.14K
+306.7%
Suzdak Peter David
Chief Executive Officer
22,250
$101.09K
+270.8%
Benaim Ely
Chief Medical Officer
4,750
$21.58K

No percentages here. This company's share count has moved by a factor of 2.6 over the window, from 31,568,457 to 83,195,823 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 225
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 17
Transactions with no price 6
Shares from compensation/vesting 18,098,737
History held since 24 Jan 2017